Reindl M - Search Results

1

Antibody biomarkers in CNS demyelinating diseases - a long and winding road.

Berger T, Reindl M. Berger T, et al. Among authors: reindl m. Eur J Neurol. 2015 Aug;22(8):1162-8. doi: 10.1111/ene.12759. Epub 2015 May 24. Eur J Neurol. 2015. PMID: 26010364 Review.

2

Bioavailability of interferon beta 1b in MS patients with and without neutralizing antibodies.

Deisenhammer F, Reindl M, Harvey J, Gasse T, Dilitz E, Berger T. Deisenhammer F, et al. Among authors: reindl m. Neurology. 1999 Apr 12;52(6):1239-43. doi: 10.1212/wnl.52.6.1239. Neurology. 1999. PMID: 10214750

3

Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.

Reindl M, Linington C, Brehm U, Egg R, Dilitz E, Deisenhammer F, Poewe W, Berger T. Reindl M, et al. Brain. 1999 Nov;122 ( Pt 11):2047-56. doi: 10.1093/brain/122.11.2047. Brain. 1999. PMID: 10545390 Clinical Trial.

4

A comparative study of the relative bioavailability of different interferon beta preparations.

Deisenhammer F, Mayringer I, Harvey J, Dilitz E, Gasse T, Stadlbauer D, Reindl M, Berger T. Deisenhammer F, et al. Among authors: reindl m. Neurology. 2000 Jun 13;54(11):2055-60. doi: 10.1212/wnl.54.11.2055. Neurology. 2000. PMID: 10851362 Clinical Trial.

5

Immunopathogenic and clinical relevance of antibodies against myelin oligodendrocyte glycoprotein (MOG) in Multiple Sclerosis.

Berger T, Reindl M. Berger T, et al. Among authors: reindl m. J Neural Transm Suppl. 2000;(60):351-60. doi: 10.1007/978-3-7091-6301-6_25. J Neural Transm Suppl. 2000. PMID: 11205153 Review.

6

Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis.

Fazekas F, Strasser-Fuchs S, Kollegger H, Berger T, Kristoferitsch W, Schmidt H, Enzinger C, Schiefermeier M, Schwarz C, Kornek B, Reindl M, Huber K, Grass R, Wimmer G, Vass K, Pfeiffer KH, Hartung HP, Schmidt R. Fazekas F, et al. Among authors: reindl m. Neurology. 2001 Sep 11;57(5):853-7. doi: 10.1212/wnl.57.5.853. Neurology. 2001. PMID: 11552016 Clinical Trial.

7

Increased intrathecal production of apolipoprotein D in multiple sclerosis.

Reindl M, Knipping G, Wicher I, Dilitz E, Egg R, Deisenhammer F, Berger T. Reindl M, et al. J Neuroimmunol. 2001 Oct 1;119(2):327-32. doi: 10.1016/s0165-5728(01)00378-2. J Neuroimmunol. 2001. PMID: 11585636

8

Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis.

Egg R, Reindl M, Deisenhammer F, Linington C, Berger T. Egg R, et al. Among authors: reindl m. Mult Scler. 2001 Oct;7(5):285-9. doi: 10.1177/135245850100700503. Mult Scler. 2001. PMID: 11724443

9

Antibody response to myelin oligodendrocyte glycoprotein and myelin basic protein depend on familial background and are partially associated with human leukocyte antigen alleles in multiplex families and sporadic multiple sclerosis.

Lutterotti A, Reindl M, Gassner C, Poustka K, Schanda K, Deisenhammer F, Berger T. Lutterotti A, et al. Among authors: reindl m. J Neuroimmunol. 2002 Oct;131(1-2):201-7. doi: 10.1016/s0165-5728(02)00271-0. J Neuroimmunol. 2002. PMID: 12458053

10

A novel and rapid assay for the detection of neutralizing antibodies against interferon-beta.

Kob M, Harvey J, Schautzer F, Kascha S, Bibl D, Egg R, Reindl M, Berger T, Deisenhammer F. Kob M, et al. Among authors: reindl m. Mult Scler. 2003 Feb;9(1):32-5. doi: 10.1191/1352458503ms889oa. Mult Scler. 2003. PMID: 12617265

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results